The Phantom MK-1 looks the part of an AI soldier. Encased in jet black steel with a tinted glass visor, it conjures a visceral dread far beyond what may be evoked by your typical humanoid robot. And ...

ADEX Big Blue Legacy 32nd Edition (Singapore Ocean Week) 2026 returns to Suntec Singapore from April 10 to 12, 2026, bringing together the global diving, ocean and sustainability community for Asia's ...

Thank you, Adi, and good morning, everyone. 2025 was a fantastic year for Voyager Technologies, Inc., which was founded just ...

Key market opportunities in Qatar's PCS and Single Window Market include expanding port infrastructure to handle a 30% increase in cargo capacity and integrating advanced technologies like IoT and big ...

SupplyOne, Inc., a value-added distributor with corrugated converting capabilities, announced today that it has acquired Specialty Packaging, LLC, a packaging solutions distributor based in East ...

FY25 Total Revenue Grew 21% Y/Y to $403.1 Million; FY25 U.S. Net Product Revenue Grew 38% Y/Y to $159.6 Million – – Q4 2025 U.S. Net Product Revenue Grew ~38% Y/Y to $43.7 Million; Q4 2025 Total ...

Denver-based virtual therapy practice unveils a redesigned website highlighting trauma-informed, relational care for ...

The Trump administration's new taxes and regulations on money transfers to Somalia could destabilize East Africa, impacting families.

Growing demand for digital dispute resolution, sector-specific expertise, and agile models is reshaping the Alternative Dispute Services Market, emphasizing proactive risk management and operational ...

MRDN READ THE FULL MDRN RESEARCH REPORT We recently met virtually with the management of Meridian Holdings Inc. (NASDAQ:MRDN) and present our takeaways in this report. Meridian Holdings is an iGaming ...

Rising LEO/MEO Constellation Deployments, Cloud-Based GSaaS Adoption, and Expanding Defense Communication Needs Drive Market Expansion.Austin, United States, March 12, 2026 (GLOBE NEWSWIRE) -- ...

Alexion, AstraZeneca Rare Disease's Koselugo (selumetinib), an oral, selective MEK inhibitor, has been approved in Canada for the treatment of adult patients with neurofibromatosis type 1 (NF1) who ...